Online citations, reference lists, and bibliographies.
← Back to Search

Colonic Delivery Of Indometacin Loaded PGA-co-PDL Microparticles Coated With Eudragit L100-55 From Fast Disintegrating Tablets.

Hesham M Tawfeek, Ahmed A H Abdellatif, Thomas J Dennison, A. Mohammed, Y. Sadiq, I. Saleem
Published 2017 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The aim of this work was to investigate the efficient targeting and delivery of indometacin (IND), as a model anti-inflammatory drug to the colon for treatment of inflammatory bowel disease. We prepared fast disintegrating tablets (FDT) containing IND encapsulated within poly(glycerol-adipate-co-ɷ-pentadecalactone), PGA-co-PDL, microparticles and coated with Eudragit L100-55 at different ratios (1:1.5, 1:1, 1:0.5). Microparticles encapsulated with IND were prepared using an o/w single emulsion solvent evaporation technique and coated with Eudragit L-100-55 via spray drying. The produced coated microparticles (PGA-co-PDL-IND/Eudragit) were formulated into optimised FTD using a single station press. The loading, in vitro release, permeability and transport of IND from PGA-co-PDL-IND/Eudragit microparticles was studied in Caco-2 cell lines. IND was efficiently encapsulated (570.15±4.2μg/mg) within the PGA-co-PDL microparticles. In vitro release of PGA-co-PDL-IND/Eudragit microparticles (1:1.5) showed significantly (p<0.05, ANOVA/Tukey) lower release of IND 13.70±1.6 and 56.46±3.8% compared with 1:1 (89.61±2.5, 80.13±2.6%) and 1:0.5 (39.46±0.9 & 43.38±3.12) after 3 and 43h at pH 5.5 and 6.8, respectively. The permeability and transport studies indicated IND released from PGA-co-PDL-IND/Eudragit microparticles had a lower permeability coefficient of 13.95±0.68×10-6cm/s compared to free IND 23.06±3.56×10-6cm/s. These results indicate the possibility of targeting anti-inflammatory drugs to the colon using FDTs containing microparticles coated with Eudragit.
This paper references
10.1007/BF02942291
Pectin microspheres for oral colon delivery: Preparation using spray drying method andin vitro release of indomethacin
Changmoon Lee (2004)
10.1081/DDC-100101266
A pH-Dependent Colon-Targeted Oral Drug Delivery System Using Methacrylic Acid Copolymers. II. Manipulation of Drug Release Using Eudragit® L100 and Eudragit S100 Combinations
M. Z. Khan (2000)
10.1016/j.carbpol.2014.05.087
Electrosprayed inulin microparticles for microbiota triggered targeting of colon.
A. K. Jain (2014)
10.1016/j.ijpharm.2009.05.066
Drug distribution in enteric microparticles.
Suchada Nilkumhang (2009)
10.1016/j.ijpharm.2014.07.030
Influence of pH and method of crystallization on the solid physical form of indomethacin.
Alessandra Dubbini (2014)
10.1016/j.ijpharm.2009.04.038
Advantages of celecoxib nanosuspension formulation and transformation into tablets.
Andrej Dolenc (2009)
10.1007/s11051-013-2204-2
Enteric-coated sustained-release nanoparticles by coaxial electrospray: preparation, characterization, and in vitro evaluation
S. Hao (2014)
10.2174/1381612822666160211141813
Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs.
A. Beloqui (2016)
Development and optimization of itopride hydrochloride fast disintegrating tablets using factorial design and response surface methodology
H. M. Tawfeek (2015)
10.1016/J.EJPB.2005.10.005
Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes.
R. I. Moustafine (2006)
10.1016/j.ijpharm.2012.10.036
Dry powder inhalation of macromolecules using novel PEG-co-polyester microparticle carriers.
Hesham M Tawfeek (2013)
Box-Behnken Designed Nanoparticles
G. Preeti (2014)
10.2147/IJN.S17900
A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
F. Li (2011)
10.3109/10837450.2011.583925
Fast and pH-dependent release of domperidone from orally disintegrating tablets
S. Assaf (2013)
10.1016/j.ijpharm.2015.07.015
Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein.
N. Kunda (2015)
10.1053/j.gastro.2011.01.055
Epidemiology and natural history of inflammatory bowel diseases.
J. Cosnes (2011)
10.1016/j.nano.2009.04.008
Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery.
B. Mishra (2010)
10.1016/j.ejpb.2012.07.014
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.
Xue-qing Wang (2012)
10.1517/17425255.1.2.175
Caco-2 cell permeability assays to measure drug absorption
R. V. van Breemen (2005)
Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs
G. Borchard (1996)
10.1016/0378-5173(93)90302-V
Uniform and improved bioavailability of newly developed rapid and sustained release suspensions of ibuprofen microspheres
Y. Kawashima (1993)
10.1080/02652040400015346
Characteristics of felodipine-located poly(ε-caprolactone) microspheres
Bum-Keun Kim (2005)
10.1002/jps.22572
In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions.
M. A. Alhnan (2011)
10.1007/s10847-016-0594-3
Insight into inclusion complexation of indomethacin nicotinamide cocrystals
H. Ali (2016)
10.1016/j.ijpharm.2012.05.023
A discriminatory intrinsic dissolution study using UV area imaging analysis to gain additional insights into the dissolution behaviour of active pharmaceutical ingredients.
Wendy L. Hulse (2012)
10.1016/j.ijpharm.2011.01.058
Electrospun diclofenac sodium loaded Eudragit® L 100-55 nanofibers for colon-targeted drug delivery.
Xiaxia Shen (2011)
10.4314/TJPR.V2I1.14577
Effect of compression force, humidity and disintegrant concentration on the disintegration and dissolution of directly compressed furosemide tablets using croscarmellose sodium as disintegrant
A. Marais (2003)
Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease.
Y. Sasaki (1997)
10.1007/s11051-013-2221-1
Biodistribution of rhodamine B fluorescence-labeled cationic nanoparticles in rats
K. Knudsen (2014)
10.3109/10837450.2013.813543
Fast disintegrating tablets of nisoldipine for intra-oral administration
G. E. El Maghraby (2014)
10.1163/156856208786440479
Engineering strategies to enhance nanoparticle-mediated oral delivery
Yvonne J. Yamanaka (2008)
10.1039/c5lc90091c
Fabrication and applications of complex-shaped microparticles via microfluidics.
K. D. Seo (2015)
10.1016/j.jsps.2014.10.001
Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review
Nidhi (2016)
10.1023/A:1011032328064
Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa
A. Lamprecht (2004)
10.1021/mp500333v
Impact of polymers on the crystallization and phase transition kinetics of amorphous nifedipine during dissolution in aqueous media.
Shweta A. Raina (2014)
10.1007/s11095-014-1538-5
Bovine Serum Albumin Adsorbed PGA-co-PDL Nanocarriers for Vaccine Delivery via Dry Powder Inhalation
N. Kunda (2014)
10.1016/j.jsps.2012.11.006
Evaluation of PEG and mPEG-co-(PGA-co-PDL) microparticles loaded with sodium diclofenac.
Hesham M Tawfeek (2013)
10.1016/j.ejpb.2009.04.015
Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability.
P. Zakeri-Milani (2009)
10.18579/JPCRKC/2014/13/3/78388
Box-Behnken Designed Nanoparticles-in-Microparticles System (NiMS) for Formulating Mouth Dissolving Tablets of Acetazolamide
Garg Preeti (2014)
Evaluation of biodegradable polyester
H. M. Tawfeek (2014)
10.1016/j.colsurfb.2016.05.038
Mucoadhesive microparticulates based on polysaccharide for target dual drug delivery of 5-aminosalicylic acid and curcumin to inflamed colon.
Haogang Duan (2016)
10.11501/3172110
Preparation, evaluation and optimization of rapidly disintegrating tablets
畢 雲霞 (2000)
10.1016/J.EJPB.2004.01.003
Design of pH-sensitive microspheres for the colonic delivery of the immunosuppressive drug tacrolimus.
A. Lamprecht (2004)
L100-55 and chitosan with different molecular weights
Luong (2014)
10.1039/c2lc21164e
Microfluidic synthesis of advanced microparticles for encapsulation and controlled release.
W. J. Duncanson (2012)
10.1155/2014/683153
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
10.1208/s12249-010-9488-7
Development of pH-sensitive Insulin Nanoparticles using Eudragit L100-55 and Chitosan with Different Molecular Weights
M. Jelvehgari (2010)
Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology
J. Cosnes (2011)
10.1016/J.ADDR.2003.10.009
Phase transformation considerations during process development and manufacture of solid oral dosage forms.
G. Zhang (2004)
10.1208/s12249-010-9387-y
Formulation and Optimization of Orodispersible Tablets of Diazepam
Khalid K. Abed (2010)
10.1039/c6lc01023g
Recent advances in engineering microparticles and their nascent utilization in biomedical delivery and diagnostic applications.
A. Choi (2017)
10.1016/S0378-5173(02)00335-6
Preparation of poly(methacrylic acid-g-poly(ethylene glycol)) nanospheres from methacrylic monomers for pharmaceutical applications.
C. Donini (2002)
10.1615/CRITREVTHERDRUGCARRIERSYST.V21.I6.10
Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies.
Y. Fu (2004)
10.2147/DDDT.S86075
Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma
Yi-Dan Chen (2015)
10.1016/J.EJPB.2008.12.013
pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model.
Abdallah Makhlof (2009)
10.2174/156720111796642246
Development of novel combined time and pH-dependent based drug delivery systems for targeting 5-fluorouracil to the colon.
Sidramappa M. Chickpetty (2011)
10.1517/17425247.2016.1114604
Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases
John Youshia (2016)
10.1016/S0378-5173(03)00157-1
The improved compaction properties of mannitol after a moisture-induced polymorphic transition.
T. Yoshinari (2003)
10.1016/j.vascn.2014.08.002
Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.
X. Jin (2014)
Poly (glycerol adipate
H. Tawfeek (2011)
10.1016/0378-5173(95)04426-4
Formulation and comparative evaluation of bioadhesive containing diclofenac sodium and commercial enteric coated tablets in-vitro and in dogs
E. Hosny (1996)
10.1002/jps.24681
Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.
Iman M. Alfagih (2015)
[Inflammatory bowel diseases].
T. Yao (2002)
10.1016/0168-3659(95)00146-8
The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
G. Borchard (1996)
10.1016/J.EJPB.2007.01.007
Dexamethasone-loaded nanoparticle-coated microparticles: correlation between in vitro drug release and drug transport across Caco-2 cell monolayers.
R. Beck (2007)
10.1208/s12249-009-9223-4
Colon Specific Delivery of Indomethacin: Effect of Incorporating pH Sensitive Polymers in Xanthan Gum Matrix Bases
L. F. A. Asghar (2009)
10.2174/1381612823666170207145420
Gut Microbiota Modulation and Anti-Inflammatory Properties of Dietary Polyphenols in IBD: New and Consolidated Perspectives.
A. Santino (2017)
10.1007/s11095-007-9394-1
Indomethacin–Saccharin Cocrystal: Design, Synthesis and Preliminary Pharmaceutical Characterization
S. Basavoju (2007)
10.1080/10717540590889664
Caco-2 Cell Culture as a Model for Famotidine Absorption
Z. Değim (2005)
locat d poly ( caprolactone) microspheres
N. K. Kunda (2015)
10.4172/2157-7439.1000357
A Formulation, Optimization and Evaluation of Controlled ReleasedAlginate Beads Loaded-Flurbiprofen
Abdellatif Aah (2016)
10.1007/s11095-011-0433-6
Poly(Glycerol Adipate-co-ω-Pentadecalactone) Spray-Dried Microparticles as Sustained Release Carriers for Pulmonary Delivery
Hesham M Tawfeek (2011)
10.1590/S0100-40422006000500019
Nanoparticle-coated organic-inorganic microparticles: experimental design and gastrointestinal tolerance evaluation
R. Beck (2006)
10.1016/j.ejpb.2011.03.015
Spray-drying enteric polymers from aqueous solutions: a novel, economic, and environmentally friendly approach to produce pH-responsive microparticles.
M. A. Alhnan (2011)
10.1002/jps.22174
Inhibiting the gastric burst release of drugs from enteric microparticles: the influence of drug molecular mass and solubility.
M. A. Alhnan (2010)
10.1016/j.msec.2016.03.086
Spray-dried Eudragit® L100 microparticles containing ferulic acid: Formulation, in vitro cytoprotection and in vivo anti-platelet effect.
J. Nadal (2016)
10.1016/j.addr.2013.05.009
Multiphase flow microfluidics for the production of single or multiple emulsions for drug delivery.
Chun-Xia Zhao (2013)
10.1208/s12249-010-9489-6
Formulation and In vitro Characterization of Eudragit® L100 and Eudragit® L100-PLGA Nanoparticles Containing Diclofenac Sodium
M. Çetin (2010)
10.1016/J.JPBA.2005.12.020
Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.
S. J. Jung (2006)
10.1016/J.CARBPOL.2008.11.026
Physical blends of starch graft copolymers as matrices for colon targeting drug delivery systems
Itziar Silva (2009)
10.3109/03639045.2011.621432
Development of sildenafil-loaded orally disintegrating tablet with new lactate salt
Si-young Jung (2012)
10.1002/jps.21626
Indomethacin polymorphs: Experimental and conformational analysis.
J. M. Aceves-Hernández (2009)
10.1016/j.ejps.2014.05.022
A novel concentration dependent amino acid ion pair strategy to mediate drug permeation using indomethacin as a model insoluble drug.
Amr Elshaer (2014)
10.3109/03639048909040204
Eudragit RL and RS Pseudolatices: Properties and Performance in Pharmaceutical Coating as a Controlled Release Membrane for Theophylline Pellets
R. Chang (1989)
10.1016/J.ADDR.2004.08.011
New oral delivery systems for treatment of inflammatory bowel disease.
D. Friend (2005)
10.1016/j.ejps.2009.04.004
Quantifying drug release from PLGA nanoparticulates.
O. Corrigan (2009)
10.1016/j.ijpharm.2010.01.026
Synthesis and characterization of poly(methoxyl ethylene glycol-caprolactone-co-methacrylic acid-co-poly(ethylene glycol) methyl ether methacrylate) pH-sensitive hydrogel for delivery of dexamethasone.
K. Wang (2010)
10.1016/J.IJPHARM.2007.07.007
Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
Tomoko Oosegi (2008)
10.1016/J.EJPS.2005.02.009
pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers.
Sibylle Neuhoff (2005)
10.1016/j.ijpharm.2015.09.034
Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles.
N. Kunda (2015)
10.3109/03639045.2013.814060
Evaluation of biodegradable polyester-co-lactone microparticles for protein delivery
Hesham M Tawfeek (2014)
10.1039/AA9841400247
Foods and beverages
K. D. Seo (1984)
10.1016/j.ijpharm.2008.05.012
Gut instincts: explorations in intestinal physiology and drug delivery.
E. McConnell (2008)



This paper is referenced by
10.1038/s41598-020-61605-y
Cetuximab Conjugated with Octreotide and Entrapped Calcium Alginate-beads for Targeting Somatostatin Receptors
Ahmed A. H. Abdellatif (2020)
10.1080/09546634.2020.1721418
Anthocyanins rich pomegranate cream as a topical formulation with anti-aging activity.
Ahmed A H Abdellatif (2020)
10.1016/J.IJPHARM.2020.119818
Omeprazole nanoparticles suspension: Development of a stable liquid formulation with a view to pediatric administration
H. Diefenthaeler (2020)
10.1080/03639045.2019.1656735
Identification of somatostatin receptors using labeled PEGylated octreotide, as an active internalization
Ahmed A H Abdellatif (2019)
10.1007/s11095-020-02938-1
Fluorescent Nanoparticles Coated with a Somatostatin Analogue Target Blood Monocyte for Efficient Leukaemia Treatment.
Ahmed A H Abdellatif (2020)
10.1016/j.ijpharm.2019.118524
Pulmonary Delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for Treatment of COPD.
A. Mohamed (2019)
10.3390/polym11101561
Poly (glycerol adipate) (PGA), an Enzymatically Synthesized Functionalizable Polyester and Versatile Drug Delivery Carrier: A Literature Update
S. M. Swainson (2019)
10.1016/j.ejps.2020.105262
Polymer/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug.
R. Peng (2020)
10.1007/978-3-030-35910-2_3
Overview of the Advantages and Disadvantages of Different Mucosal Sites for the Delivery of Nanoparticles
K. Kaneko (2020)
10.1016/J.PROGPOLYMSCI.2019.02.005
Polymers from macrolactones: from pheromones to functional materials
J. Wilson (2019)
10.1016/j.jsps.2019.02.001
Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization
N. Atia (2019)
10.1016/j.jconrel.2019.01.023
Drying technology strategies for colon‐targeted oral delivery of biopharmaceuticals
Panna Vass (2019)
10.1080/03639045.2020.1716376
Soluplus® based solid dispersion as fast disintegrating tablets: a combined experimental approach for enhancing the dissolution and antiulcer efficacy of famotidine
M. Basha (2020)
10.3390/ijms20246210
Polyglycerol Hyperbranched Polyesters: Synthesis, Properties and Pharmaceutical and Biomedical Applications
Alexandra Zamboulis (2019)
10.1016/j.ijpharm.2019.01.022
A review on 5‐aminosalicylic acid colon‐targeted oral drug delivery systems
Hossein Shahdadi Sardo (2019)
Somatostatin Decorated Quantum Dots for Targeting of Somatostatin Receptors
Ahmed Abdelfattah Hafez Abdellatif (2018)
10.1016/j.colsurfb.2018.09.001
Lotus leaf-inspired design of calcium alginate particles with superhigh drug encapsulation efficiency and pH responsive release.
B. Song (2018)
10.1016/j.msec.2018.04.071
Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function.
Jiahua Zhou (2018)
10.1007/978-3-030-44925-4_2
Applications of Nanopharmaceuticals in Delivery and Targeting
M. Ibrahim (2021)
10.4172/2153-2435.1000593
Design of Sustained Action Dosage Forms; Mini-Review
Aah Abdellatif (2018)
10.1016/J.JDDST.2017.10.022
A novel controlled release microsponges containing Albendazole against Haemonchus contortus in experimentally infected goats
Ahmed A. H. Abdellatif (2018)
10.3390/molecules24081501
Formulation of Ethyl Cellulose Microparticles Incorporated Pheophytin A Isolated from Suaeda vermiculata for Antioxidant and Cytotoxic Activities
H. Mohammed (2019)
10.1007/978-3-030-35910-2
Mucosal Delivery of Drugs and Biologics in Nanoparticles
Pavan Muttil (2020)
10.24377/LJMU.T.00012213
PULMONARY DELIVERY OF RESVERATROL-LOADED NANOCOMPOSITE MICROPARTICLES TO TREAT LUNG CANCER
A. Muller (2020)
10.1016/j.microc.2019.104321
Integrative physicochemical and HPLC assessment studies for the inclusion of lornoxicam in buffalo's milk fat globules as a potential carrier delivery system for lipophilic drugs
Ahmed A. H. Abdellatif (2020)
Semantic Scholar Logo Some data provided by SemanticScholar